AbdulhamidBazarbachiMD

PubMed

• 6 citations
  High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination.
  Lauren C Shapiro, Astha Thakkar, Radhika Gali, Jesus D Gonzalez-Lugo, Abdul-Hamid Bazarbachi
  Leukemia & Lymphoma. 2022-10-01
• TCL-150 Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.
  Hiba Narvel, Abdul-Hamid Bazarbachi, Daniel Reef, Riya Patel, Astha Thakkar
  Clinical Lymphoma, Myeloma & Leukemia. 2022-10-01
• 20 citations
  Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update.
  Abdul Hamid Bazarbachi, Rama Al Hamed, Florent Malard, Ali Bazarbachi, Jean-Luc Harousseau
  Blood Cancer Journal. 2022-03-28

Journal Articles

• Allogeneic transplant for FLT3-ITD mutated AML: advances and challenges  
  Bazarbachi AH, Al Hamed R, Malard F, Mohty M, Bazarbachi A, Therapeutic Advances in Hematology, 7/2019
• A Phase 2 Study of Hyper-CVAD plus Ofatumumab as Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia (ALL): Updated results  
  Bazarbachi AH, Yilmaz M, Ravandi F, Thomas D, Khouri M, Garcia-Manero G, Garris R, Cortes J, Short N, Sasaki K, Issa G, Koller P, Schroeder H, Kadia T, Verstovsek S, D..., Journal of Clinical Oncology, 5/2018
• How I treat and monitor non-transfusion-dependent thalassaemia  
  Bazarbachi AH, Moukhadder H, Bou Fakhredin R, Roumi J, Chaya B, Taher A, Haematologica, 3/2017
• Immune thrombocytopenia: a comprehensive review from pathophysiology to promising treatment modalities  
  Moukhadder H, Chaya B, Bazarbachi AH, Taher A, Expert Opinion on Orphan Drugs, 10/2016
• Non-Transfusion-Dependent Thalassaemia: A Panoramic Survey from Pathophysiology to Treatment  
  Bazarbachi AH, Chaya B, Moukhadder H, Taher A, EMJ, 7/2016
• Join now to see all

Abstracts/Posters

• Allogeneic stem cell transplantation (allo-SCT) with sequential conditioning in patients with primary refractory or relapsed adult acute lymphoblastic leukemia: a repo...
  Bazarbachi AH, Al Hamed R, Labopin M, Afanasyev B, Hamladji RM, Beelen D, Ganser A, Scheid C, Wu D, Bunjes D, Stepensky P, Tischer J, Kröger N, Peric Z, Giebel S, Nagl..., European Society for Blood and Marrow Transplantation, Frankfurt, DEU, 3/2019
• Azacitidine (AZA) For Prophylaxis or Pre-emptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation
  Marini C, Brissot E, Bazarbachi AH, Dulery R, Sestili S, Battipaglia G, Mediavilla C, Paviglianiti A, Belhocine R, Isnard F, Lapusan S, Adaeva R, Vekhoff A, Ledraa T, ..., European Society for Blood and Marrow Transplantation, Frankfurt, DEU, 3/2019
• A Phase 2 Study of Hyper-CVAD plus Ofatumumab as Frontline Therapy in CD20+ Acute Lymphoblastic Leukemia (ALL): Updated results
  Bazarbachi AH, Yilmaz M, Ravandi F, Thomas D, Khouri M, Garcia-Manero G, Garris R, Cortes J, Short N, Sasaki K, Issa G, Koller P, Schroeder H, Kadia T, Verstovsek S, D..., American Society of Clinical Oncology, Chicago, IL, USA, 6/2018